CD8A and urinary bladder cancer: Autogene cevumeran-induced T cells directed against one of the neoantigens persisted for several months in a patient with bladder cancer (patient 66), which constituted >11% of circulating CD8 T cells at day 232 (Extended Data Fig. 3c).